Scientist at ICMR–NICHR, New Delhi, India, specialising in haemato-oncology, holds an MD Pathology and fellowship in Hemato-Oncology from Tata Medical Centre. A recipient of the ISLH-Berend-Houwen Award and the Harold Gunson Best Oral Paper Award, she has over 69 PubMed-indexed publications and holds two patents in leukemia diagnostics.

Tamia Nguyen is a medical scientist and PhD student at Molecular Pathology department at Peter MacCallum Cancer Centre.

Adi is an early-career haematologist with subspecialty interest in multi-omic diagnostics and MRD medicine. Following completion of his HSANZ Clinical Fellowship at King's College London, he has returned to Melbourne and currently serves as a molecular haematologist at the Alfred and Austin Health.

Dr. Sanjeev Kumar Gupta is Professor of Laboratory Oncology at AIIMS, New Delhi, with training in hematopathology. He is an award-winning researcher with extensive work in genomic characterization of B-cell acute lymphoblastic leukemia, including copy number alterations, molecular genetics, MRD, targeted and whole transcriptome sequencing, and has over 58 publications.

Sarah Clarke is a PhD student at the University of Western Australia, specialising in haematological analysis of multiple myeloma, with particular focus on chromosomal abnormalities and advanced detection methods. Her work involves using imaging flow cytometry to detect critical genetic lesions in plasma cells.

Dr Ing Soo Tiong is a clinical and laboratory haematologist at the Peter MacCallum Cancer Centre and Royal Melbourne Hospital, where his work integrates molecular diagnostics with the care of patients with acute leukaemia and myeloid neoplasms. He led the VALDAC trial of MRD-directed therapy in AML and serves on the European LeukemiaNet AML MRD Working Group.